HTA / Affairs & Scientific Communication Ltd / SMEs / Medium Size Enterprise / /
Continent
Europe / /
Country
Germany / Switzerland / Hungary / Estonia / Slovenia / Cyprus / Poland / France / Slovakia / United Kingdom / Lithuania / Czech Republic / /
Currency
EUR / / /
Event
M&A / /
Facility
UK’s National Institute / Such as The National Institute / /
IndustryTerm
value products / biotechnology-based industry / health technology assessment / health care technology / prospective new medical technologies / healthcare / pharmaceutical / healthcare systems / treatment for the same disease / medicinal products / health technologies / certain medical technology / medical technology / biotechnology associations / pharmaceutical prices / reward healthcare innovation / health systems / literature search / /
European Association for Bioindustries / National Institute for Health and Clinical Excellence / European Medicines Agency / European Commission / EuropaBio / Institute for Quality and Efficiency / European Union / Efficiency in Health Care / National Institute for Clinical ExcellenceNICE / UK’s National Institute for Clinical ExcellenceNICE / /
Person
Anna Hallersten / / /
Position
Manager / Executive / Director SFL Public Affairs / /
RadioStation
Europe 1 / /
Region
Central Europe / Eastern Europe / /
Technology
Health Technology / biotechnology / medical technology / health care technology / health technologies / Europe Health technology / certain medical technology / drug development / /
Report: Impact of HTA Health Technology Assessment requirements on SMEs Small and Medium sized Enterprises in Europe